CSI Market
Sign In | Register

Sqz Biotechnologies (SQZB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SQZB Annual Cash Flow →
The quarterly cash flow data below helps track how Sqz Biotechnologies's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2023)
9 Months 		(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Operating Activities
Income-58.10
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.72
Increase (Decrease) in Restructuring Reserve-2.99
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.11
Share-based Compensation2.83
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Amortization Of Operating Lease Right Of Use Assets-
Gain Loss On Termination Of Lease-
Depreciation And Amortization Including Restructuring Charges1.04
Operating Lease Right Of Use Asset Amortization Expense7.02
Increase Decrease In Operating Lease Liabilities-6.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.60
Increase (Decrease) in Accrued Liabilities-4.54
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.60
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5.99
Discontinued operations0.00
Net Cash flow from Operating Activities-53.57
Investing Activities
Capital Expenditures-0.11
Sale of Capital Items0.17
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.06
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-66.01
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents66.01
Purchases Of Property And Equipment Included In Accrued Expenses-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Deferred Offering Costs Included In Accrued Expenses And Accounts Payable-
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan-
Proceeds From Issuance Of Common Stock Under At The Market Offering Of Common Stock Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-53.52
Total Cash Flow-53.52
4 historic quarters locked

Sign in to unlock the full Sqz Biotechnologies cash flow history.

Sign In Create Free Account

About Sqz Biotechnologies Co Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-061187

Figures are derived from filed reports and may be restated. Historical data is subject to revision.